The Wistar Institute is recognized as a global leader in biomedical research, particularly in the fields of cancer, vaccine development, and immunotherapy. The institute is designated as a Cancer Center by the National Cancer Institute (NCI) and has made significant strides in basic research, exemplified by the recent recognition of the Ellen and Ronald Caplan Cancer Center with a Cancer Center Support Grant Merit Extension. This highlights Wistar's commitment to advancing cancer research and developing innovative therapies, including new combination approaches for treating metastatic ovarian cancer and exploring novel treatments for pancreatic cancer.

In addition to its cancer research initiatives, The Wistar Institute emphasizes the importance of immunology and virology through its Vaccine & Immunotherapy Center. This center aims to leverage the institute's expertise to enhance public health on a global scale. Furthermore, Wistar is dedicated to education and training in biomedical research, as evidenced by the establishment of the Hubert J.P. Schoemaker Education and Training Center, which consolidates various programs to foster impactful research and collaboration. Through these efforts, Wistar is positioned to make significant contributions to the future of biomedical science and public health.

United States

The Wistar Institute is a biomedical research institution that focuses on advancing knowledge in life sciences and medical research.

The Wistar Institute

Company Details